The evidence on peptides — delivered weekly. Subscribe free →

Matrixyl

low risk

Also: Palmitoyl Pentapeptide-4 · Palmitoyl Pentapeptide-3 · Pal-KTTKS

Moderate Evidence Research Only

Matrixyl is a palmitoylated fragment of collagen that signals the skin to produce more collagen, elastin, and fibronectin. It is one of the most studied and evidence-supported cosmetic peptides, with multiple independent clinical trials demonstrating anti-aging efficacy.

Molecular Weight
676.9 g/mol
Formula
C32H60N6O8S
Common Dosing
Topical: 3-8 ppm (active peptide) in formulation
Category
cosmetic
Last Reviewed
2025-01-15

Reported Benefits

Collagen Stimulation

Moderate Evidence 20 studies

In vitro and in vivo studies confirm collagen I, III, and IV synthesis stimulation.

Wrinkle Reduction

Moderate Evidence 18 studies

Multiple RCTs show 27-68% wrinkle depth reduction with 8 weeks of use.

Skin Firmness

Moderate Evidence 12 studies

Improved skin elasticity and firmness documented in clinical studies.

Mechanism of Action

Matrixyl (Pal-KTTKS) is a fragment of procollagen type I with a palmitoyl group for skin penetration. It activates TGF-beta pathways and integrin receptors on fibroblasts, upregulating expression of collagen types I, III, and IV, elastin, and fibronectin. It also reduces matrix metalloproteinases that break down existing collagen.

Key Clinical Studies

Katayama K et al. (1993)

controlled · 24 subjects

Palmitoyl pentapeptide stimulates collagen synthesis in fibroblasts and reduces wrinkle depth

Robinson LR et al. (2005)

RCT · 93 women

Significant improvement in facial wrinkle parameters over 12 weeks

Overview

Matrixyl, developed by Sederma and introduced in 2000, became one of the foundational ingredients in evidence-based cosmetic formulation. Unlike many cosmetic ingredients backed by no controlled trial data, matrixyl has accumulated a meaningful independent evidence base across multiple laboratories.

Matrixyl 3000

A newer formulation, Matrixyl 3000, combines palmitoyl pentapeptide-4 with palmitoyl tetrapeptide-7 (anti-inflammatory component). The combination targets both collagen synthesis and inflammatory matrix degradation simultaneously — a more comprehensive anti-aging approach.

Concentration Reality

The active peptide concentration in commercial formulations varies enormously. Some products list “matrixyl” but contain only trace amounts. Effective concentrations of palmitoyl pentapeptide-4 are in the 3-8 ppm range for the active ingredient — which translates to specific product formulation requirements that most consumers cannot verify from the label.

Mechanism Distinction

Unlike argireline (which acts on neuromuscular junctions) and GHK-Cu (which has broad gene regulatory effects), matrixyl’s mechanism is specifically focused on the extracellular matrix — stimulating the structural proteins that give skin its firmness and reducing the enzymes that degrade them.

Regulatory Status

Research Only

Cosmetic ingredient; INCI name Palmitoyl Pentapeptide-4; no FDA drug approval

Safety Profile

Side Effects

  • •Skin irritation (rare)
  • •Contact sensitization (rare)

Contraindications

  • •Known sensitivity to palmitate esters

Drug Interactions

  • •None established

Primary Uses

Collagen stimulationAnti-agingWrinkle reductionSkin firmness

Related Peptides

ghk-cuargirelinematrixyl-3000snap-8

Weekly Briefing

Regulatory updates + new study breakdowns.

For Practitioners

Do you prescribe Matrixyl?

Get in front of patients who've already researched this protocol and are ready to consult. Featured listings from $199/mo.

Get Listed →
Disclaimer: This information is for educational and research purposes only. Not medical advice. Consult a qualified healthcare provider before using any compound.